Official websites use .gov
Secure .gov websites use HTTPS
Titles
- Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry1
- Amyotrophic lateral sclerosis: developing drugs for treatment1
- An analysis of private-sector prices for hospital admissions1
- An analysis of private-sector prices for physicians' services1
- An estimated 91 percent of nursing home staff nationwide received the required COVID-19 vaccine doses, and an estimated 56 percent of staff nationwide received a booster dose1
- An evaluation of CBO's past outlay projections1
- An insurance profile of rural America: chartbook : key facts about insurance coverage and healthcare access in rural America1
- An updated policy roadmap: caring for those with complex needs1
- Analysis of 2017 premium changes and insurer participation in the Affordable Care Act's health insurance marketplaces1
- Anesthesia services: differences between private and Medicare payments likely due to providers' strong negotiating position : report to Congressional committees1
- Animal use in research: NIH should strengthen oversight of projects it funds at foreign facilities : report to congressional requesters1
- Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry1
- Answering the call: 988 : a new vision for crisis response1
- Answers to questions for the record following a hearing conducted by the House Committee on the Budget: key design components and considerations for establishing a single-payer health care system1
- Anthrax: developing drugs for prophylaxis of inhalational anthrax1
- Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases1
- Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact1
- Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters1
- Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters1